Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Eric Van Cutsem

90Y-edotreotide for metastatic carcinoid refractory to octreotide

scientific article

A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma

scientific article published on 22 September 2008

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen

scientific article

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials

scientific article

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study ⬇️

scientific article published on September 13, 2010

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials

scientific article

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

scientific article published on 15 June 2004

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

scientific article

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

scientific article published on 16 November 2012

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

scientific article published on 31 August 2015

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

scientific article (publication date: 2 April 2009)

Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer

scientific article published on October 2006

Clinical presentation and pathophysiology of EGFRI dermatologic toxicities

scientific article published on October 2007

Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study

scientific article

Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database

scientific article

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

scientific article

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

scientific article

Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials

scientific article

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

scientific article published on 18 November 2005

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

scientific article published on 04 September 2007

Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer

scientific article

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

scientific article

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

scientific article

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

scientific article

Everolimus for advanced pancreatic neuroendocrine tumors.

scientific article

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group

scientific article published on January 2008

Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial

scientific article

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting ⬇️

scientific article published on January 24, 2011

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

scientific article

Hepatic radiation injury mimicking metastasis in distal esophageal cancer

scientific article published on 27 October 2016

Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians

scientific article

Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database

scientific article published on 03 June 2013

Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trial

scientific article

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report

scientific article

Integration of the anti-EGFR agent panitumumab into clinical practice in metastatic colorectal cancer

scientific article published on August 2007

Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer

scientific article

Leptomeningeal carcinomatosis associated with oesophageal adenocarcinoma: two case reports and review of the literature

scientific article published on October 2006

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

scientific article

Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda).

scientific article published in January 2004

Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus

scientific article

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer

scientific article

Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks

scientific article

Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review

scientific article published on 03 June 2020

Molecular and genetic defects in colorectal tumorigenesis

scientific article

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

scientific article published on October 2006

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

scientific article

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

scientific article

Oral capecitabine: bridging the Atlantic divide in colon cancer treatment

scientific article

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

scientific article published on 01 December 2020

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

scientific article

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

scientific article

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

scientific article published on 09 August 2018

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer

scientific article (publication date: 2013)

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

scientific article

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

scientific article published on 01 October 2020

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies

scientific article

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

scientific article

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

scientific article published on 29 March 2010

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

scientific article

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, doubl

scientific article

Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer

scientific article published on 8 March 2017

Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.

scientific article published on October 2017

Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer

scientific article

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

scientific article

Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer

scientific article

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.

scientific article published on 25 March 2015

Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis ⬇️

scientific article published on January 24, 2013

Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial

scientific article published on 26 March 2013

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

scientific article

Systemic treatment of pancreatic cancer

scientific article published on March 2004

T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the VHgene mutation status ⬇️

scientific article published on February 15, 2011

The causes and consequences of cancer-associated malnutrition

scientific article

The continuum of care: a paradigm for the management of metastatic colorectal cancer

scientific article published on January 2007

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

scientific article

The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer

scientific article published on January 2007

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus

scientific article

The role of chemotherapy in the current treatment of gastric cancer

scientific article

The treatment of advanced colorectal cancer: where are we now and where do we go?

scientific article

The treatment of advanced gastric cancer: new findings on the activity of the taxanes.

scientific article published on January 2004

Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

scientific article published on 10 August 2006

Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study

scientific article

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

scientific article

Tumor response and symptom palliation from RAINBOW, a phase 3 trial of ramucirumab plus paclitaxel in previously treated advanced gastric cancer

scientific article published on 03 December 2020

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

scientific article

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

scientific article

Paulina is supported by:

About Paulina

Help